Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study.
Comparative study
Diffusion-weighted magnetic resonance imaging
Magnetic resonance imaging
Radiation
Uterine cervical neoplasm
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
18
11
2017
accepted:
20
04
2018
revised:
28
03
2018
pubmed:
27
6
2018
medline:
12
2
2019
entrez:
27
6
2018
Statut:
ppublish
Résumé
To compare MR imaging with or without DWI and clinical response evaluation (CRE) in the local control evaluation of cervical carcinoma after radiotherapy. In a multicentre university setting, we prospectively included 107 patients with primary cervical cancer treated with radiotherapy. Sensitivity and specificity for CRE and MR imaging (with pre-therapy MR imaging as reference) (2 readers) were evaluated using cautious and strict criteria for identifying residual tumour. Nested logistic regression models were constructed for CRE, subsequently adding MR imaging with and without DWI as independent variables, as well as the pre- to post-treatment change in apparent diffusion coefficient (delta ADC). Using cautious criteria, CRE and MR imaging with DWI (reader 1/reader 2) have comparable high specificity (83% and 89%/95%, respectively), whereas MR imaging without DWI showed significantly lower specificity (63%/53%) than CRE. Using strict criteria, CRE and MR imaging with DWI both showed very high specificity (99% and 92%/95%, respectively), whereas MR imaging without DWI showed significantly lower specificity (89%/77%) than CRE. All sensitivities were not significantly different. Addition of MR imaging with DWI to CRE has statistically significant incremental value in identifying residual tumour (reader 1: estimate, 1.06; p = 0.001) (reader 2: estimate, 0.62; p = 0.02). Adding the delta ADC did not have significant incremental value in detecting residual tumour. DWI significantly increases the specificity of MR imaging in the detection of local residual tumour. Furthermore, MR imaging with DWI has significant incremental diagnostic value over CRE, whereas adding the delta ADC has no incremental diagnostic value. • If MR imaging is used for response evaluation, DWI should be incorporated • MR imaging with DWI has diagnostic value comparable/complementary to clinical response evaluation • Inter-reader agreement is moderate to fair for two experienced radiologist readers • Quantitative measurements of ADC early post-therapy have limited diagnostic value.
Identifiants
pubmed: 29943182
doi: 10.1007/s00330-018-5510-3
pii: 10.1007/s00330-018-5510-3
pmc: PMC6291430
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
309-318Subventions
Organisme : Nuts-Ohra
ID : 1002-043
Références
Gynecol Oncol. 2000 Aug;78(2):187-93
pubmed: 10926801
Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):442-8
pubmed: 11567819
Obstet Gynecol. 2002 May;99(5 Pt 1):855-67
pubmed: 11978302
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002225
pubmed: 16034873
Cancer. 2008 Oct 15;113(8):2158-65
pubmed: 18780318
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):713-8
pubmed: 19427739
Gynecol Oncol. 2009 Sep;114(3):528-35
pubmed: 19560188
Radiology. 2009 Oct;253(1):116-25
pubmed: 19789256
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006377
pubmed: 20091593
Clin Oncol (R Coll Radiol). 2010 Sep;22(7):590-601
pubmed: 20594810
Radiother Oncol. 2010 Aug;96(2):153-60
pubmed: 20663578
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):609-14
pubmed: 21215531
Ann Surg Oncol. 2011 Aug;18(8):2224-31
pubmed: 21347783
Radiother Oncol. 2011 Jul;100(1):116-23
pubmed: 21821305
Ann Oncol. 2012 Oct;23 Suppl 7:vii27-32
pubmed: 22997451
Eur Radiol. 2013 Jul;23(7):2005-18
pubmed: 23455762
Acta Oncol. 2013 Oct;52(7):1510-9
pubmed: 23962242
Eur J Surg Oncol. 2013 Dec;39(12):1428-34
pubmed: 24183796
Radiology. 2014 Feb;270(2):454-63
pubmed: 24471390
J Magn Reson Imaging. 2015 Sep;42(3):572-94
pubmed: 25346470
Clin Breast Cancer. 2015 Oct;15(5):370-80
pubmed: 25891905
Eur J Surg Oncol. 2015 Aug;41(8):975-85
pubmed: 25922209
Eur Radiol. 2016 Sep;26(9):3272-9
pubmed: 26685853
Curr Oncol. 2016 Apr;23(2):109-18
pubmed: 27122975
Radiology. 2017 Aug;284(2):432-442
pubmed: 28301309